Enantiomer separation through membrane-based approaches: A review

Abstract

The development of single-enantiomer drug from racemate chiral drugs is a challenging field in pharmaceutical industries which has opened a new market strategy for pharmaceutical firms. In this review, two types of membrane-based approaches for separation of chiral drugs are highlighted which are Supported Liquid Membrane (SLM) and Enzymatic Membrane Reactor (EMR). The present overview attempts to cover the current review in separation of chiral drugs and some understanding of the advantages of using these methods.